Cargando…
Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda
This cost-outcome study estimated, from the perspective of the service provider, the total annual cost per client on antiretroviral therapy (ART) and total annual cost per client virally suppressed (defined as < 1000 copies/ml at the time of the study) in Uganda in five ART differentiated service...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635081/ https://www.ncbi.nlm.nih.gov/pubmed/36329450 http://dx.doi.org/10.1186/s12913-022-08629-4 |
_version_ | 1784824630830170112 |
---|---|
author | Guthrie, Teresa Muheki, Charlotte Rosen, Sydney Kanoowe, Shiba Lagony, Stephen Greener, Ross Miot, Jacqueline Balidawa, Hudson Kiggundu, Josen Calnan, Jacqueline Dejene, Seyoum Xulu, Thembi Sigwebela, Ntombi Long, Lawrence C |
author_facet | Guthrie, Teresa Muheki, Charlotte Rosen, Sydney Kanoowe, Shiba Lagony, Stephen Greener, Ross Miot, Jacqueline Balidawa, Hudson Kiggundu, Josen Calnan, Jacqueline Dejene, Seyoum Xulu, Thembi Sigwebela, Ntombi Long, Lawrence C |
author_sort | Guthrie, Teresa |
collection | PubMed |
description | This cost-outcome study estimated, from the perspective of the service provider, the total annual cost per client on antiretroviral therapy (ART) and total annual cost per client virally suppressed (defined as < 1000 copies/ml at the time of the study) in Uganda in five ART differentiated service delivery models (DSDMs). These included both facility- and community-based models and the standard of care (SOC), known as the facility-based individual management (FBIM) model. The Ministry of Health (MOH) adopted guidelines for DSDMs in 2017 and sought to measure their costs and outcomes, in order to effectively plan for their resourcing, implementation, and scale-up. In Uganda, the standard of care (FBIM) is considered as a DSDM option for clients requiring specialized treatment and support, or for those who select not to join an alternative DSDM. Note that clients on second-line regimes and considered as “established on treatment” can join a suitable DSDM. Using retrospective client record review of a cohort of clients over a two-year period, with bottom-up collection of clients’ resource utilization data, top-down collection of above-delivery level and delivery-level providers’ fixed operational costs, and local unit costs. Forty-seven DSDMs located at facilities or community-based points in the four regions of Uganda were included in the study, with 653 adults on ART (> 18 years old) enrolled in a DSDM. The study found that retention in care was 98% for the sample as a whole [96–100%], and viral suppression, 91% [86-93%]. The mean cost to the provider (MOH or NGO implementers) was $152 per annum per client treated, ranging from $141 to $166. Differences among the models’ costs were largely due to clients’ ARV regimens and the proportions of clients on second line regimens. Service delivery costs, excluding ARVs, other medicines and laboratory tests, were modest, ranging from $9.66–16.43 per client per year. We conclude that differentiated ART service delivery in Uganda achieved excellent treatment outcomes at a cost similar to the standard of care. While large budgetary savings might not be immediately realized, the reallocation of “saved” staff time could improve health system efficiency and with their equivalent or better outcomes and large benefits to clients, client-centred differentiated models would nevertheless add great societal value. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-08629-4. |
format | Online Article Text |
id | pubmed-9635081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96350812022-11-05 Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda Guthrie, Teresa Muheki, Charlotte Rosen, Sydney Kanoowe, Shiba Lagony, Stephen Greener, Ross Miot, Jacqueline Balidawa, Hudson Kiggundu, Josen Calnan, Jacqueline Dejene, Seyoum Xulu, Thembi Sigwebela, Ntombi Long, Lawrence C BMC Health Serv Res Research This cost-outcome study estimated, from the perspective of the service provider, the total annual cost per client on antiretroviral therapy (ART) and total annual cost per client virally suppressed (defined as < 1000 copies/ml at the time of the study) in Uganda in five ART differentiated service delivery models (DSDMs). These included both facility- and community-based models and the standard of care (SOC), known as the facility-based individual management (FBIM) model. The Ministry of Health (MOH) adopted guidelines for DSDMs in 2017 and sought to measure their costs and outcomes, in order to effectively plan for their resourcing, implementation, and scale-up. In Uganda, the standard of care (FBIM) is considered as a DSDM option for clients requiring specialized treatment and support, or for those who select not to join an alternative DSDM. Note that clients on second-line regimes and considered as “established on treatment” can join a suitable DSDM. Using retrospective client record review of a cohort of clients over a two-year period, with bottom-up collection of clients’ resource utilization data, top-down collection of above-delivery level and delivery-level providers’ fixed operational costs, and local unit costs. Forty-seven DSDMs located at facilities or community-based points in the four regions of Uganda were included in the study, with 653 adults on ART (> 18 years old) enrolled in a DSDM. The study found that retention in care was 98% for the sample as a whole [96–100%], and viral suppression, 91% [86-93%]. The mean cost to the provider (MOH or NGO implementers) was $152 per annum per client treated, ranging from $141 to $166. Differences among the models’ costs were largely due to clients’ ARV regimens and the proportions of clients on second line regimens. Service delivery costs, excluding ARVs, other medicines and laboratory tests, were modest, ranging from $9.66–16.43 per client per year. We conclude that differentiated ART service delivery in Uganda achieved excellent treatment outcomes at a cost similar to the standard of care. While large budgetary savings might not be immediately realized, the reallocation of “saved” staff time could improve health system efficiency and with their equivalent or better outcomes and large benefits to clients, client-centred differentiated models would nevertheless add great societal value. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-08629-4. BioMed Central 2022-11-03 /pmc/articles/PMC9635081/ /pubmed/36329450 http://dx.doi.org/10.1186/s12913-022-08629-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Guthrie, Teresa Muheki, Charlotte Rosen, Sydney Kanoowe, Shiba Lagony, Stephen Greener, Ross Miot, Jacqueline Balidawa, Hudson Kiggundu, Josen Calnan, Jacqueline Dejene, Seyoum Xulu, Thembi Sigwebela, Ntombi Long, Lawrence C Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title | Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title_full | Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title_fullStr | Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title_full_unstemmed | Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title_short | Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda |
title_sort | similar costs and outcomes for differentiated service delivery models for hiv treatment in uganda |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635081/ https://www.ncbi.nlm.nih.gov/pubmed/36329450 http://dx.doi.org/10.1186/s12913-022-08629-4 |
work_keys_str_mv | AT guthrieteresa similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT muhekicharlotte similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT rosensydney similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT kanooweshiba similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT lagonystephen similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT greenerross similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT miotjacqueline similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT balidawahudson similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT kiggundujosen similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT calnanjacqueline similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT dejeneseyoum similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT xuluthembi similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT sigwebelantombi similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda AT longlawrencec similarcostsandoutcomesfordifferentiatedservicedeliverymodelsforhivtreatmentinuganda |